The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Abstral 200 microgram sublingual tablets.
|Batch Number||Expiry Date||Pack Size||First Distributed|
|608777302||31 July 2021||30 Tablets||24 December 2019|
Kyowa Kirin Limited is recalling the tablets batch as a precautionary measure, due to the reports of double tablets in a single blister pocket.
This was identified during reference sample inspection and there is a potential low risk of accidental double dosage.
The pharmacists have been adviced to stop supplying the batch immediately and quarantine all remaining stock and return it to their supplier.